Twist Bioscience Corporation Common Stock
TWSTTwist Bioscience Corporation is a biotechnology company known for its innovative synthetic DNA manufacturing platform. Founded to enable rapid and cost-effective production of high-quality DNA, Twist serves a range of industries including healthcare, agriculture, and industrial applications. The company's platform utilizes a proprietary silicon-based synthesis process, allowing for high-throughput and scalable DNA synthesis essential for research, drug development, and diagnostics.
Company News
The DNA computing market is projected to grow from $293.70 million in 2025 to $2.68 billion by 2032, with a 36.76% CAGR, driven by innovations in data storage, cryptography, and molecular computing technologies.
The global cell culture microcarriers market is projected to grow from USD 3.45 billion in 2025 to USD 7.2 billion by 2034, with an 8.54% CAGR, driven by advancements in biopharmaceuticals, cell therapies, and regenerative medicine research.
The DNA data storage market is expected to grow from $76 million in 2024 to $3,348 million by 2030, with a CAGR of 87.7%. The market is driven by increasing cybersecurity concerns and the need for secure, compact data storage solutions, particularly in healthcare and biotechnology sectors.
Twist Bioscience reported strong Q3 results with 18% revenue growth, achieving profitability through a one-time gain and improved operational efficiency. The company saw growth in Next Generation Sequencing and strategic product launches while managing slower Synthetic Biology segment performance.
The antibody discovery market is projected to grow at a 10% CAGR by 2032, driven by increasing chronic disease incidence, biologics adoption, and technological advancements in drug development.
